The World Health Organization standards for tuberculosis care and management Source: Eur Respir J, 51 (3) 1800098; 10.1183/13993003.00098-2018 Year: 2018
Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics Source: Eur Respir J 2016; 47:1867-1869 Year: 2016
European Union standard for tuberculosis care on treatment of multidrug-resistant tuberculosis following new World Health Organization recommendations Source: Eur Respir J, 52 (5) 1801617; 10.1183/13993003.01617-2018 Year: 2018
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update Source: Eur Respir J, 57 (6) 2003300; 10.1183/13993003.03300-2020 Year: 2021
The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines Source: Eur Respir J, 54 (4) 1901272; 10.1183/13993003.01272-2019 Year: 2019
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe Source: Eur Respir J, 53 (6) 1900391; 10.1183/13993003.00391-2019 Year: 2019
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update Source: Eur Respir J , 49 (3) 1602308; DOI: 10.1183/13993003.02308-2016 Year: 2017
World Health Organization treatment outcome definitions for tuberculosis: 2021 update Source: Eur Respir J, 58 (2) 2100804; 10.1183/13993003.00804-2021 Year: 2021
Public health guidance on programmatic management of latent tuberculosis infection in the European Union/European Economic Area Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I Year: 2019
New definitions of extensively drug resistant tuberculosis: update from the World Health Organization Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease Year: 2021
The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis Source: Annual Congress 2011 - Multidrug-resistant tuberculosis Year: 2011
World Health Organization guidance on the treatment of isoniazid-resistant tuberculosis Source: International Congress 2018 – New developments in tuberculosis Year: 2018
New treatment outcome definitions for drug-susceptible and drug-resistant tuberculosis: update from World Health Organization Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
Implementation of digital health interventions in respiratory medicine: a call to action by the European Respiratory Society m-Health/e-Health Group Source: ERJ Open Res, 6 (1) 00281-2019; 10.1183/23120541.00281-2019 Year: 2020
Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country Source: Eur Respir J 2017; 49(1): 1601967; DOI: 10.1183/13993003.01967-2016 Year: 2017
Resources and support of the World Health Organization to improve air quality Source: International Congress 2019 – Is your patient dying from air pollution? Year: 2019
New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization Source: Eur Respir J, 57 (4) 2100361; 10.1183/13993003.00361-2021 Year: 2021
The European union standards for tuberculosis care: Do they need an update? Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014